Clinical trials in heart transplantation: The evolution of evidence in immunosuppression-Reference-Cited by-同舟云学术

Clinical trials in heart transplantation: The evolution of evidence in immunosuppression

Published:2017-12 Issue:12 Volume:36 Page:1286-1290
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Kobashigawa Jon

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference17 articles.

1. Human heart transplantation: current status;Griepp;Ann Thorac Surg,1976

2. The long-term course of cyclosporine-associated chronic nephropathy;Myers;Kidney Int,1988

3. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients;Kobashigawa;Transplantation,1998

4. European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results—European Tacrolimus Multicenter Heart Study Group;Reichart;J Heart Lung Transplant,1998

5. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus;Taylor;J Heart Lung Transplant,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Transplantation: A Bibliometric Review From 1990-2021;Current Problems in Cardiology;2022-08

2. The Association Between Tacrolimus Levels and Hyperkalemia in Allograft Recipients Who Underwent Heart or Lung Transplantation in New Orleans, USA Between 2013 and 2019: A Single-Center Retrospective Study;Annals of Transplantation;2022-06-20

3. Post-transplant Management in Heart Transplant Recipients: New Drugs and Prophylactic Strategies;Current Treatment Options in Cardiovascular Medicine;2021-06-03

4. Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection;Ochsner Journal;2021

5. Antiproliferatives and Transplantation;Pharmacology of Immunosuppression;2021